| Industry Range | | Price / Earnings | N/A | |
| Book Value | 0.00 | |
| Earnings Per Share | -$0.02 | |
| Price To Sales Ratio | 55.93 | |
| Price To Book Ratio | 23.83 | |
| Price To Tangible Book Ratio | 23.87 | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 15.4M | |
| Float (MRQ) | 98.21% | |
| Shares Outstanding (MRQ) | 275.9M | |
| Short Interest as a % of Float (MRQ) | N/A | |
| Shares Held By Institutions (MRQ) | N/A | |
| Industry Range | | Sales | $285.3K | |
| Gross Margin | 34.25% | |
| Net Profit Margin | -1,269.70% | |
| EBIT Margin | -1,186.65% | |
| EBITDA Margin | -1,184.72% | |
| Operating Margins | -1,186.65% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 2.05 | |
| Quick Ratio (MRQ) | 1.52 | |
| Total Debt/Equity Ratio (MRQ) | 44.79 | |
| Debt/Common Equity Ratio (MRQ) | 44.79 | |
| Industry Range | | Return on Equity | -634.27% | |
| Return on Assets | -220.63% | |
| Asset Turnover | 0.17 | |
| Receivables Turnover | 2.37 | |
| Inventory Turnover | 0.56 | |
| Industry Range | | EPS Growth Annual | -42.11% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | N/A | |
*TAUG does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.68%